Answers are grounded in this paper and cite their sources.
Quantitative analysis of iron levels using MRI in patients with Alzheimer’s disease and mild cognitive impairment highlights its potential role in neurodegeneration.
Motivation: Iron dysregulation and deposition may play a role in neurodegeneration in Alzheimer's disease (AD), but limited studies have pushed the boundaries of MRI resolution to accurately quantify iron, particularly in the hippocampus. Goal(s): Utilize ultra-high resolution MRI and QSM for quantitative analysis of hippocampal subfield iron deposition to investigate the role of brain iron in AD. Approach: We acquired 7T multi-echo gradient echo MRI on 19 living human subjects (healthy, mild cognitive impairment, AD) to detect hippocampal source-separated QSM/R2* abnormalities and quantify iron concentrations within hippocampal subfields. Results: Increased R2* and QSM-χ+ was detected in the subiculum-CA1 hippocampal subfields with worsening disease status. Impact: This study successfully performed in vivo ultra-high resolution MRI to quantify iron deposition in hippocampi of MCI and AD patients, contributing to the development of iron as a neuroimaging biomarker for AD.
No takes yet. Share an insight, caveat, or question.
Dunne et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: